Cargando…
Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize Performance
The 2019 coronavirus (COVID-19) pandemic revealed the urgent need for the acceleration of vaccine development worldwide. Rapid vaccine development poses numerous risks for each category of vaccine technology. By using the Risklick artificial intelligence (AI), we estimated the risks associated with...
Autores principales: | Haas, Quentin, Borisov, Nikolay, Alvarez, David Vicente, Ferdowsi, Sohrab, von Meyenn, Leonhard, Teodoro, Douglas, Amini, Poorya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593331/ https://www.ncbi.nlm.nih.gov/pubmed/34796360 http://dx.doi.org/10.3389/fdgth.2021.745674 |
Ejemplares similares
-
Deep learning-based risk prediction for interventional clinical trials based on protocol design: A retrospective study
por: Ferdowsi, Sohrab, et al.
Publicado: (2023) -
Information Retrieval in an Infodemic: The Case of COVID-19 Publications
por: Teodoro, Douglas, et al.
Publicado: (2021) -
Reducing systematic review burden using Deduklick: a novel, automated, reliable, and explainable deduplication algorithm to foster medical research
por: Borissov, Nikolay, et al.
Publicado: (2022) -
AI chatbots not yet ready for clinical use
por: Au Yeung, Joshua, et al.
Publicado: (2023) -
Erroneous data: The Achilles' heel of AI and personalized medicine
por: Kristiansen, Thomas Birk, et al.
Publicado: (2022)